Cargando…
Efficacy of Direct-Acting Antivirals in Patients with Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Gap between Clinical Trial and Real Practice
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254617/ https://www.ncbi.nlm.nih.gov/pubmed/30466200 http://dx.doi.org/10.5009/gnl18418 |
_version_ | 1783373762474803200 |
---|---|
author | Kim, Do Young |
author_facet | Kim, Do Young |
author_sort | Kim, Do Young |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6254617 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Editorial Office of Gut and Liver |
record_format | MEDLINE/PubMed |
spelling | pubmed-62546172018-11-26 Efficacy of Direct-Acting Antivirals in Patients with Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Gap between Clinical Trial and Real Practice Kim, Do Young Gut Liver Editorial Editorial Office of Gut and Liver 2018-11 2018-11-15 /pmc/articles/PMC6254617/ /pubmed/30466200 http://dx.doi.org/10.5009/gnl18418 Text en Copyright © 2018 by The Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, Korean Pancreatobiliary Association, and Korean Society of Gastrointestinal Cancer. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorial Kim, Do Young Efficacy of Direct-Acting Antivirals in Patients with Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Gap between Clinical Trial and Real Practice |
title | Efficacy of Direct-Acting Antivirals in Patients with Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Gap between Clinical Trial and Real Practice |
title_full | Efficacy of Direct-Acting Antivirals in Patients with Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Gap between Clinical Trial and Real Practice |
title_fullStr | Efficacy of Direct-Acting Antivirals in Patients with Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Gap between Clinical Trial and Real Practice |
title_full_unstemmed | Efficacy of Direct-Acting Antivirals in Patients with Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Gap between Clinical Trial and Real Practice |
title_short | Efficacy of Direct-Acting Antivirals in Patients with Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Gap between Clinical Trial and Real Practice |
title_sort | efficacy of direct-acting antivirals in patients with hepatitis c virus/human immunodeficiency virus coinfection: a gap between clinical trial and real practice |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254617/ https://www.ncbi.nlm.nih.gov/pubmed/30466200 http://dx.doi.org/10.5009/gnl18418 |
work_keys_str_mv | AT kimdoyoung efficacyofdirectactingantiviralsinpatientswithhepatitiscvirushumanimmunodeficiencyviruscoinfectionagapbetweenclinicaltrialandrealpractice |